Document is current
Any future updates will be listed below
-
Authors
Gruell, Henning https://orcid.org/0000-0002-0725-7138
Vanshylla, Kanika https://orcid.org/0000-0003-4552-9170
Tober-Lau, Pinkus https://orcid.org/0000-0002-9148-3663
Hillus, David https://orcid.org/0000-0002-3138-9050
Schommers, Philipp
Lehmann, Clara
Kurth, Florian https://orcid.org/0000-0002-3807-473X
Sander, Leif E. https://orcid.org/0000-0002-0476-9947
Klein, Florian https://orcid.org/0000-0003-1376-1792
-
Funding
Funding for this research was provided by:
Deutsches Zentrum für Infektionsforschung
Deutsche Forschungsgemeinschaft (CRC1310)
Bundesministerium für Bildung und Forschung (01KX2021)
Bundesministerium für Bildung und Forschung (01KX2021)
Bundesinstitut für Arzneimittel und Medizinprodukte (Federal Institute for Drugs and Medical Devices)
- License Information
-
More Information
Article History
Received: 13 December 2021
Accepted: 22 December 2021
First Online: 19 January 2022
Competing interests
: H.G., K.V. and F. Klein are listed as inventors on pending patent application(s) on SARS-CoV-2-neutralizing antibodies filed by the University of Cologne. All other authors have no competing interests.
